Europe — EMA
Olanzapina Aurobindo Pharma Italia (Olanzapine)
Olanzapine, the active ingredient in Olanzapina Aurobindo Pharma Italia, is an atypical antipsychotic presented as a oral medication for oral use. It treats schizophrenia and bipolar disorder in adults and adolescents.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapina Aurobindo Pharma Italia, is an atypical antipsychotic presented as a oral medication for oral use. It treats schizophrenia and bipolar disorder in adults and adolescents. GNH USA supplies Olanzapina Aurobindo Pharma Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olanzapina Aurobindo Pharma Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapine is an atypical antipsychotic that modulates dopamine and serotonin pathways in psychiatric disorders.
- Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Bipolar disorder: Stabilises mood during manic or mixed episodes and supports maintenance therapy. - Psychotic depression: Alleviates depressive symptoms with psychotic features when used as an adjunct. - Schizoaffective disorder: Controls both psychotic and mood components of the illness. - Tourette syndrome: May reduce frequency and severity of motor and vocal tics. - Off‑label : Use for other psychi ‑ but not endorsed by regulators.
What are the side effects of Olanzapine?
Olanzapine may … … … … … … … … … … … …
Common i t t t \
